Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Hyun Seung Ban, Yoshikazu Uto & Hiroyuki Nakamura. (2021) Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2016–2020). Expert Opinion on Therapeutic Patents 31:5, pages 387-397.
Read now
Read now
Bhuvaneshwar Vaidya, Matthew Pangallo, Gregoire Ruffenach, Christine Marie Cunningham, Jeanette C. Perron, Srikanth Kolluru, Mansoureh Eghbali & Vivek Gupta. (2017) Advances in treatment of pulmonary arterial hypertension: patent review. Expert Opinion on Therapeutic Patents 27:8, pages 907-918.
Read now
Read now
Sourabh Soni & Yogendra S. Padwad. (2017) HIF-1 in cancer therapy: two decade long story of a transcription factor. Acta Oncologica 56:4, pages 503-515.
Read now
Read now
Zhaoting Li, Yijia Zhu, Chenchen Li, Ryan Trinh, Xueyan Ren, Fumou Sun, Youfu Wang, Pengzhao Shang, Tong Wang, Min Wang, Sherie L. Morrison & Juan Zhang. (2017) Anti-VEGFR2-interferon-α2 regulates the tumor microenvironment and exhibits potent antitumor efficacy against colorectal cancer. OncoImmunology 6:3.
Read now
Read now
Articles from other publishers (34)
Rafia Akhlaq, Tajwali Khan, Tehmina Ahmed, Syed G. Musharraf & Arslan Ali. (2023) PX‐12 synergistically enhances the therapeutic efficacy of vorinostat under hypoxic tumor microenvironment in oral squamous cell carcinoma in vitro. Drug Development Research 84:3, pages 606-610.
Crossref
Crossref
Je Lin Sieow, Hweixian Leong Penny, Sin Yee Gun, Ling Qiao Tan, Kaibo Duan, Joe Poh Sheng Yeong, Angela Pang, Diana Lim, Han Chong Toh, Tony Kiat Hon Lim, Edgar Engleman, Olaf Rotzschke, Lai Guan Ng, Jinmiao Chen, Suet Mien Tan & Siew Cheng Wong. (2023) Conditional Knockout of Hypoxia-Inducible Factor 1-Alpha in Tumor-Infiltrating Neutrophils Protects against Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 24:1, pages 753.
Crossref
Crossref
Chuanshan Yao & Feng Wang. (2022) Inhibition of hypoxia‐induced HIF‐1α‐mediated autophagy enhances the in vitro antitumor activity of rhein in pancreatic cancer cells. Journal of Applied Toxicology 42:12, pages 1937-1947.
Crossref
Crossref
Abdul Rahman, Prashanth N, Nippu B N, H M Kumaraswamy, A N Rajeshwara & N D Satyanarayan. (2022) Synthesis and anticancer screening of some novel Pd-catalysed 3-methyl indole based analogues on Mia PaCa-2 cell line. Journal of Molecular Structure 1264, pages 133211.
Crossref
Crossref
Essa M. Sabi, Anuja Singh, Ziyad M. Althafar, Tapan Behl, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Saurabh Bhatia, Ahmed Al-Harrasi, Hosam M. Alqahtani & Simona Bungau. (2022) Elucidating the role of hypoxia-inducible factor in rheumatoid arthritis. Inflammopharmacology 30:3, pages 737-748.
Crossref
Crossref
Xuesong Liu, Ruru Guo, Shicheng Huo, Huan Chen, Qingxiang Song, Gan Jiang, Ye Yu, Jialin Huang, Shaowei Xie, Xiaoling Gao & Liangjing Lu. (2022) CaP-based anti-inflammatory HIF-1α siRNA-encapsulating nanoparticle for rheumatoid arthritis therapy. Journal of Controlled Release 343, pages 314-325.
Crossref
Crossref
Bo Meng, Fang-yuan Liu, Ming-ming Liu, Liang-chen Yu, Wen-ting Zhang, Meng-yuan Zhou, Si-yu Liu, Rong Li & Li Cai. (2022) AMSP-30 m as a novel HIF-1α inhibitor attenuates the development and severity of adjuvant-induced arthritis in rats: Impacts on synovial apoptosis, synovial angiogenesis and sonic hedgehog signaling pathway. International Immunopharmacology 103, pages 108467.
Crossref
Crossref
Lovis Kling, Adrian Schreiber, Kai-Uwe Eckardt & Ralph Kettritz. (2021) Hypoxia-inducible factors not only regulate but also are myeloid-cell treatment targets. Journal of Leukocyte Biology 110:1, pages 61-75.
Crossref
Crossref
Naseim Elzakra & Yong Kim. 2021. Cancer Metabolomics. Cancer Metabolomics
243
260
.
Tiansheng Li, Chao Mao, Xiang Wang, Ying Shi & Yongguang Tao. (2020) Epigenetic crosstalk between hypoxia and tumor driven by HIF regulation. Journal of Experimental & Clinical Cancer Research 39:1.
Crossref
Crossref
Inhyub Kim, Minkyoung Kim, Min Kyung Park, Ravi Naik, Jae Hyung Park, Bo-Kyung Kim, Yongseok Choi, Kwan Young Chang, Misun Won, Hyun Seung Ban & Kyeong Lee. (2020) The disubstituted adamantyl derivative LW1564 inhibits the growth of cancer cells by targeting mitochondrial respiration and reducing hypoxia-inducible factor (HIF)-1α accumulation. Experimental & Molecular Medicine 52:11, pages 1845-1856.
Crossref
Crossref
Joyobrato Nath, Rajib Paul, Sankar Kumar Ghosh, Jaishree Paul, Baby Singha & Nitu Debnath. (2020) Drug repurposing and relabeling for cancer therapy: Emerging benzimidazole antihelminthics with potent anticancer effects. Life Sciences 258, pages 118189.
Crossref
Crossref
Jacob T. Bush, Mun Chiang Chan, Shabaz Mohammed & Christopher J. Schofield. (2020) Quantitative MS‐Based Proteomics: Comparing the MCF‐7 Cellular Response to Hypoxia and a 2‐Oxoglutarate Analogue. ChemBioChem 21:11, pages 1647-1655.
Crossref
Crossref
Rui-Xue Huang & Ping-Kun Zhou. (2020) DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Signal Transduction and Targeted Therapy 5:1.
Crossref
Crossref
Anna Adamiok-Ostrowska & Agnieszka Piekiełko-Witkowska. (2020) Ciliary Genes in Renal Cystic Diseases. Cells 9:4, pages 907.
Crossref
Crossref
Alessia Capone & Elisabetta Volpe. (2020) Transcriptional Regulators of T Helper 17 Cell Differentiation in Health and Autoimmune Diseases. Frontiers in Immunology 11.
Crossref
Crossref
Shinichiro Fuse, Kensuke Suzuki, Takahiro Kuchimaru, Tetsuya Kadonosono, Hiroki Ueda, Shinichi Sato, Shinae Kizaka-Kondoh & Hiroyuki Nakamura. (2020) Design, synthesis, and evaluation of indeno[2,1-c]pyrazolones for use as inhibitors against hypoxia-inducible factor (HIF)-1 transcriptional activity. Bioorganic & Medicinal Chemistry 28:1, pages 115207.
Crossref
Crossref
Guangzhe Li, Huijuan Dong, Yao Ma, Kun Shao, Yueqing Li, Xiaodan Wu, Shisheng Wang, Yujie Shao & Weijie Zhao. (2019) Structure-activity relationships study of neolamellarin A and its analogues as hypoxia inducible factor-1 (HIF-1) inhibitors. Bioorganic & Medicinal Chemistry Letters 29:16, pages 2327-2331.
Crossref
Crossref
Jingli Gong, Shengxue Zhou & Shihai Yang. (2019) Vanillic Acid Suppresses HIF-1α Expression via Inhibition of mTOR/p70S6K/4E-BP1 and Raf/MEK/ERK Pathways in Human Colon Cancer HCT116 Cells. International Journal of Molecular Sciences 20:3, pages 465.
Crossref
Crossref
Josh W. DiGiacomo & Daniele M. Gilkes. 2019. Hypoxia and Cancer Metastasis. Hypoxia and Cancer Metastasis
141
157
.
Deepak Bhattarai, Xuezhen Xu & Kyeong Lee. (2018) Hypoxia-inducible factor-1 (HIF-1) inhibitors from the last decade (2007 to 2016): A “structure-activity relationship” perspective. Medicinal Research Reviews 38:4, pages 1404-1442.
Crossref
Crossref
Josh W. DiGiacomo & Daniele M. Gilkes. (2018) Tumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies. Targeted Oncology 13:2, pages 157-173.
Crossref
Crossref
A. Al-Soudi, M.H. Kaaij & S.W. Tas. (2017) Endothelial cells: From innocent bystanders to active participants in immune responses. Autoimmunity Reviews 16:9, pages 951-962.
Crossref
Crossref
Sanghyuck Lee, Oh Seok Kwon, Chang-Soo Lee, Misun Won, Hyun Seung Ban & Choon Sup Ra. (2017) Synthesis and biological evaluation of kresoxim-methyl analogues as novel inhibitors of hypoxia-inducible factor (HIF)-1 accumulation in cancer cells. Bioorganic & Medicinal Chemistry Letters 27:13, pages 3026-3029.
Crossref
Crossref
Alejandro Roman-Gonzalez & Camilo Jimenez. (2017) Malignant pheochromocytoma–paraganglioma. Current Opinion in Endocrinology & Diabetes and Obesity 24:3, pages 174-183.
Crossref
Crossref
Hyun Seung Ban, Bo-Kyung Kim, Hongsub Lee, Hwan Mook Kim, Dipesh Harmalkar, Miso Nam, Song-Kyu Park, Kiho Lee, Joon-Tae Park, Inhyub Kim, Kyeong Lee, Geum-Sook Hwang & Misun Won. (2017) The novel hypoxia-inducible factor-1α inhibitor IDF-11774 regulates cancer metabolism, thereby suppressing tumor growth. Cell Death & Disease 8:6, pages e2843-e2843.
Crossref
Crossref
Xiaobo Zhou, Ming Chen, Zhiyuan Zheng, Guo-Yuan Zhu, Zhi-Hong Jiang & Li-Ping Bai. (2017) Synthesis and evaluation of novel 12-aryl berberine analogues with hypoxia-inducible factor-1 inhibitory activity. RSC Advances 7:43, pages 26921-26929.
Crossref
Crossref
F. Morinet, M. Parent, S. Pillet, M. Koken, C. Lebbé & C. Capron. (2017) Hypoxia inducible factor one alpha and human viral pathogens. Current Research in Translational Medicine 65:1, pages 7-9.
Crossref
Crossref
Shinichiro Fuse, Toshiaki Ohuchi, Yasunobu Asawa, Shinichi Sato & Hiroyuki Nakamura. (2016) Development of 1-aryl-3-furanyl/thienyl-imidazopyridine templates for inhibitors against hypoxia inducible factor (HIF)-1 transcriptional activity. Bioorganic & Medicinal Chemistry Letters 26:24, pages 5887-5890.
Crossref
Crossref
Hyun Seung Ban, Xuezhen Xu, Kusik Jang, Inhyub Kim, Bo-Kyung Kim, Kyeong Lee & Misun Won. (2016) A Novel Malate Dehydrogenase 2 Inhibitor Suppresses Hypoxia-Inducible Factor-1 by Regulating Mitochondrial Respiration. PLOS ONE 11:9, pages e0162568.
Crossref
Crossref
A.I. Karseladze. (2016) Intraepithelial ischemia is a principal factor promoting cancerization of the covering epithelial tissues. Medical Hypotheses 94, pages 154-160.
Crossref
Crossref
Sarah E. Corcoran & Luke A.J. O’Neill. (2016) HIF1α and metabolic reprogramming in inflammation. Journal of Clinical Investigation 126:10, pages 3699-3707.
Crossref
Crossref
Hyun Seung Ban, Ravi Naik, Hwan Mook Kim, Bo-Kyung Kim, Hongsub Lee, Inhyub Kim, Heechul Ahn, Yerin Jang, Kyusik Jang, Yumi Eo, Kyung Bin Song, Kyeong Lee & Misun Won. (2016) Identification of Targets of the HIF-1 Inhibitor IDF-11774 Using Alkyne-Conjugated Photoaffinity Probes. Bioconjugate Chemistry 27:8, pages 1911-1920.
Crossref
Crossref
Susan Hua & Thilani H. Dias. (2016) Hypoxia-Inducible Factor (HIF) as a Target for Novel Therapies in Rheumatoid Arthritis. Frontiers in Pharmacology 7.
Crossref
Crossref